SKWD news & sentiment — Skyward Specialty Insurance Group, Inc.

MAY 21·IndexBoxMed

Wall Street's Mixed Signals: One Buy, Two Sells in May 2026 Analysis

A recent StockStory analysis reveals Wall Street's divided opinions on three stocks, with a buy recommendation for Skyward Specialty Insurance (SKWD) and sell signals for Transcat (TRNS) and Purple (PRPL). While analysts generally project significant upside, sell ratings are rare due to potential conflicts of interest. The report outlines specific financial concerns for TRNS and PRPL, contrasting them with SKWD's strong performance indicators.

MAY 7·www.sharewise.com

Skyward Specialty Q1 Earnings Beat on Apollo Lift, Premium Growth

Skyward Specialty Insurance Group, Inc. (SKWD) reported strong first-quarter 2026 results, with operating earnings per share increasing 38.9% year-over-year and beating analyst estimates. Total revenues surged 44.8%, driven by stronger premiums, improved underwriting results, and the accretive impact of its Apollo acquisition. The company's premium base expanded across both its Skyward Specialty and Apollo segments, with a notable decrease in its combined ratio, indicating improved profitability.

MAR 19·MSN

How Skyward's niche playbook shields it from pricing pressure & cycles

This article examines how Skyward protects itself from pricing pressures and economic cycles by focusing on niche market strategies. The content of the article is not available to provide further details.

$SKWD

Wall Street's Mixed Signals: One Buy, Two Sells in May 2026 Analysis

Skyward Specialty Q1 Earnings Beat on Apollo Lift, Premium Growth

How Skyward's niche playbook shields it from pricing pressure & cycles

News on $SKWD